Quick Answer
Enveric Biosciences, Inc. reported Net Income of -$8.77 million for fiscal year 2025.
Enveric Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$8.77M | +8.4% |
| 2024 | -$9.57M | +44.6% |
| 2023 | -$17.29M | +6.4% |
| 2022 | -$18.47M | +62.3% |
| 2021 | -$48.98M | -613.5% |
| 2020 | -$6.86M | -184.8% |
| 2019 | -$2.41M | +85.7% |
| 2018 | -$16.90M | -86.2% |
| 2017 | -$9.07M | -226.4% |
| 2016 | -$2.78M | -8165.0% |
| 2014 | -$33.6K | -20796.9% |
| 2013 | -$161.00 | +99.3% |
| 2012 | -$24.6K | +26.2% |
| 2011 | -$33.4K | +15.4% |
| 2010 | -$39.4K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.87M | +10.1% | +25.6% |
| June 30, 2025 | -$2.52M | -34.0% | -15.3% |
| March 31, 2025 | -$2.18M | +11.1% | -4.8% |
| September 30, 2024 | -$2.08M | +26.2% | -10.9% |
| June 30, 2024 | -$1.88M | +70.4% | +23.5% |
| March 31, 2024 | -$2.46M | +47.5% | +12.9% |
| September 30, 2023 | -$2.82M | -13.8% | +55.6% |
| June 30, 2023 | -$6.36M | -127.8% | -35.9% |
- Enveric Biosciences, Inc. showed an increase of +8.4% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Enveric Biosciences, Inc.’s net income has declined by 22140.8% (from -$39.4 thousand to -$8.77 million).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: